Charifson, Paul S.,Clark, Michael P.,Bandarage, Upul K.,Bethiel, Randy S.,Boyd, Michael J.,Davies, Iona,Deng, Hongbo,Duffy, John P.,Farmer, Luc J.,Gao, Huai,Gu, Wenxin,Kennedy, Joseph M.,Ledford, Bria
申请号：
AU2012290127
公开号：
AU2012290127A1
申请日:
2012.08.01
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
